Gene Expression-Based Predictive Markers for Paclitaxel Treatment in ER+ and ER− Breast Cancer

Frontiers in Genetics - Switzerland
doi 10.3389/fgene.2019.00156
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

A 16 Yin Yang Gene Expression Ratio Signature for ER+/node− Breast Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age

Advances in Therapy
MedicinePharmacology
2015English

Evaluating an ER Degrader for Breast Cancer

Cancer Discovery
Oncology
2015English

First-Line Abemaciclib Effective in ER+ Breast Cancer

Cancer Discovery
Oncology
2017English

Estrogen Receptor (ER) mRNA Expression and Molecular Subtype Distribution in ER-negative/progesterone Receptor-Positive Breast Cancers

Breast Cancer Research and Treatment
Cancer ResearchOncology
2013English

Targeting Estrogen Receptor Subtypes (ER and ER ) With Selective ER Modulators in Ovarian Cancer

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2014English

Pictilisib Plus Anastrozole Reduces Proliferation in ER+ Breast Cancer

Cancer Discovery
Oncology
2016English

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines

PLoS ONE
Multidisciplinary
2012English

Treating ER+ Breast Cancer With CDK4/6 Inhibitors

Cancer Discovery
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy